Naudingos nuorodos
What is being done to prevent possible shortages of medicines due to BREXIT?

The State Medicines Control Agency is closely monitoring and analyzing the situation in the Register of Medicinal Products of the Republic of Lithuania for the purpose of ensuring that the supply of medicines would not be affected by BREXIT. All the instructions of the European Commission are being implemented, actively cooperation with pharmaceutical manufacturers, registrants and suppliers is being done, the all issues are being resolved and the possibilities of substitutability of medicines are being clarified. The situation is now fully managed and clear.


Despite the fact that the SMCA has taken all necessary measures to prevent possible supply disruptions, the latter may be caused by logistical problems at the border with the United Kingdom.
 
More relevant information on this issue can be found on the website of the European Medicines Agency (EMA). Find it by clicking here